 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Screening Strategies for Colorectal Cancer
17 October 2000 | Volume 133 Issue 8 | Page I-16
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician.
The summary below is from the full report titled "Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer." It is in the 17 October 2000 issue of Annals of Internal Medicine (volume 133, pages 573-584). The authors are A Sonnenberg, F Delcò, and JM Inadomi.
What is the problem and what is known about it so far?
Cancer of the colon or rectum (colorectal cancer) is the second leading cause of death from cancer in the United States. Polyps are noncancerous outgrowths of the wall of the colon or rectum that can become cancerous. Screening tests prevent some colorectal cancers by detecting and removing polyps before they become cancers and by detecting cancers in their early stages, when they can still be cured with surgery. The available screening tests are fecal occult blood testing (FOBT), flexible sigmoidoscopy, and colonoscopy. Fecal occult blood testing uses a simple chemical reaction to detect blood hidden in stool. Since polyps and colorectal cancers can cause blood to leak into the stool, a positive FOBT suggests the need for further testing. Flexible sigmoidoscopy involves looking into the rectum and lower colon through a tube-shaped instrument; colonoscopy uses a similar but longer instrument to look at the entire colon. It is possible to take samples of the colon (biopsies) and remove polyps during both procedures. Fecal occult blood testing is inexpensive, colonoscopy is very expensive, and costs of sigmoidoscopy are somewhere in between. It is not clear which screening strategy makes the most sense in terms of costs and associated benefits.
Why did the researchers do this particular study?
To compare the cost-effectiveness of screening patients for colorectal cancer by using FOBT every year, flexible sigmoidoscopy every 5 years, or colonoscopy every 10 years, beginning at 50 years of age.
Who was studied?
Rather than studying actual patients, the researchers used a computer model to simulate what would happen to a "virtual" group of 50-year-old patients considering screening for colon cancer. They assumed that patients had no special risks for colon cancer, such as a positive family history.
How was the study done?
The researchers used information from actual patients to estimate what might happen when patients were screened by using the three strategies and how much each strategy would cost for each year of life it saves. They used these estimates in their computer model.
What did the researchers find?
Compared with no screening, yearly screening with FOBT prevents 18% of all colorectal cancers, sigmoidoscopy every 5 years prevents 34%, and colonoscopy every 10 years prevents 75%. Colonoscopy also results in more years of life saved. For each year of life saved, FOBT costs $81,678, sigmoidoscopy costs $74,031, and colonoscopy costs $28,143.
What were the limitations of the study?
This study was a computer simulation, so we cannot be sure what the results would be in actual patients. However, studies of this problem using actual patients are unlikely to be done soon (if ever).
What are the implications of the study?
Colonoscopy every 10 years beginning at 50 years of age is a more effective, and more cost-effective, way to screen for colorectal cancer than FOBT every year or sigmoidoscopy every 5 years.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  K E Nnoaham and C Lines Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme Gut, September 1, 2008; 57(9): 1238 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Sandler Aspirin Should Not Be Promoted for Colon Cancer Prevention: Counterpoint Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1562 - 1563. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Pickhardt, C. Hassan, A. Laghi, A. Zullo, D. H. Kim, F. Iafrate, and S. Morini Small and Diminutive Polyps Detected at Screening CT Colonography: A Decision Analysis for Referral to Colonoscopy Am. J. Roentgenol., January 1, 2008; 190(1): 136 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Braithwaite, J. Concato, C. C. Chang, M. S. Roberts, and A. C. Justice A Framework for Tailoring Clinical Guidelines to Comorbidity at the Point of Care Arch Intern Med, November 26, 2007; 167(21): 2361 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Brenner, J. Chang-Claude, C. M. Seiler, T. Sturmer, and M. Hoffmeister Potential for Colorectal Cancer Prevention of Sigmoidoscopy Versus Colonoscopy: Population-Based Case Control Study Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 494 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Ramsey How Should We Pay the Piper When He's Calling the Tune? On the Long-Term Affordability of Cancer Care in the United States J. Clin. Oncol., January 10, 2007; 25(2): 175 - 179. [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Basch, R. L. Wolf, C. H. Brouse, C. Shmukler, A. Neugut, L. T. DeCarlo, and S. Shea Telephone Outreach to Increase Colorectal Cancer Screening in an Urban Minority Population Am J Public Health, December 1, 2006; 96(12): 2246 - 2253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Brenner, J Chang-Claude, C M Seiler, T Sturmer, and M Hoffmeister Does a negative screening colonoscopy ever need to be repeated? Gut, August 1, 2006; 55(8): 1145 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. T. Shih, L. Zhao, and L. S. Elting Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly? Health Aff., July 1, 2006; 25(4): 1153 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Ramsey, W. Burke, L. Pinsky, L. Clarke, P. Newcomb, and M. J. Khoury Family History Assessment to Detect Increased Risk for Colorectal Cancer: Conceptual Considerations and a Preliminary Economic Analysis Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2494 - 2500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Heitman, B. J. Manns, R. J. Hilsden, A. Fong, S. Dean, and J. Romagnuolo Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening Can. Med. Assoc. J., October 11, 2005; 173(8): 877 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pignone, S. Saha, T. Hoerger, K. N. Lohr, S. Teutsch, and J. Mandelblatt Challenges in Systematic Reviews of Economic Analyses Ann Intern Med, June 21, 2005; 142(12_Part_2): 1073 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Schoenfeld, B. Cash, A. Flood, R. Dobhan, J. Eastone, W. Coyle, J. W. Kikendall, H. M. Kim, D. G. Weiss, T. Emory, et al. Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia N. Engl. J. Med., May 19, 2005; 352(20): 2061 - 2068. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Hao, D. H. Moore, P. Wong, J. L. Bennington, N. M. Lee, and L.-C. Chen Alteration of Gene Expression in Macroscopically Normal Colonic Mucosa from Individuals with a Family History of Sporadic Colon Cancer Clin. Cancer Res., February 15, 2005; 11(4): 1400 - 1407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Subramanian, M. M. Amonkar, and T. L. Hunt Use of Colonoscopy for Colorectal Cancer Screening: Evidence from the 2000 National Health Interview Survey Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 409 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Boer, S. Plevritis, and L. Clarke Diversity of model approaches for breast cancer screening: a review of model assumptions by The Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups Statistical Methods in Medical Research, December 1, 2004; 13(6): 525 - 538. [Abstract] [PDF]
|
|
|
|
|
|
J. E. Lafata, J. Simpkins, L. Lamerato, L. Poisson, G. Divine, and C. C. Johnson The Economic Impact of False-Positive Cancer Screens Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2126 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Battat, R. V. Rouse, L. Dempsey, B. Y. Safadi, and S. M. Wren Institutional Commitment to Rectal Cancer Screening Results in Earlier-Stage Cancers on Diagnosis Ann. Surg. Oncol., November 1, 2004; 11(11): 970 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Provenzale and R. N. Gray Colorectal Cancer Screening and Treatment: Review of Outcomes Research J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 45 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Sisk, W. Whang, J. C. Butler, V.-P. Sneller, and C. G. Whitney Cost-Effectiveness of Vaccination against Invasive Pneumococcal Disease among People 50 through 64 Years of Age: Role of Comorbid Conditions and Race Ann Intern Med, June 17, 2003; 138(12): 960 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. E. Walsh and J. P. Terdiman Colorectal Cancer Screening: Clinical Applications JAMA, March 12, 2003; 289(10): 1297 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D A L Macafee and J H Scholefield Population based endoscopic screening for colorectal cancer Gut, March 1, 2003; 52(3): 323 - 326. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Lewis, K. Ng, K. E. Hung, W. B. Bilker, J. A. Berlin, C. Brensinger, and A. K. Rustgi Detection of Proximal Adenomatous Polyps With Screening Sigmoidoscopy: A Systematic Review and Meta-analysis of Screening Colonoscopy Arch Intern Med, February 24, 2003; 163(4): 413 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M. Gatto, H. Frucht, V. Sundararajan, J. S. Jacobson, V. R. Grann, and A. I. Neugut Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-Based Study J Natl Cancer Inst, February 5, 2003; 95(3): 230 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Janda, W. R. Stanton, K. Hughes, C. Del Mar, A. Clavarino, J. F. Aitken, Shilu Tong, L. Short, B. Leggett, and B. Newman Knowledge, Attitude and Intentions Related to Colorectal Cancer Screening Using Faecal Occult Blood Tests in a Rural Australian Population Asia Pac J Public Health, January 1, 2003; 15(1): 50 - 56. [Abstract] [PDF]
|
|
|
|
 |
|
 D. K. Whynes The economic case for faecal occult blood screening Ann. Onc., December 1, 2002; 13(12): 1953 - 1955. [Full Text] [PDF]
|
|
|
|
 |
|
 S. D Ramsey Incorporating economic analysis into clinical practice guidelines: a guide for hopeful users Evid. Based Med., November 1, 2002; 7(6): 164 - 166. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Donaldson, G. Currie, and C. Mitton Cost effectiveness analysis in health care: contraindications BMJ, October 19, 2002; 325(7369): 891 - 894. [Full Text] [PDF]
|
|
|
|
|
|
M. Pignone, S. Saha, T. Hoerger, and J. Mandelblatt Cost-Effectiveness Analyses of Colorectal Cancer Screening: A Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med, July 16, 2002; 137(2): 96 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Imperiale, D. R. Wagner, C. Y. Lin, G. N. Larkin, J. D. Rogge, and D. F. Ransohoff Results of Screening Colonoscopy among Persons 40 to 49 Years of Age N. Engl. J. Med., June 6, 2002; 346(23): 1781 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. James, M. K. Campbell, and M. A. Hudson Perceived Barriers and Benefits to Colon Cancer Screening among African Americans in North Carolina: How Does Perception Relate to Screening Behavior? Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Neri, P. Giusti, L. Battolla, P. Vagli, P. Boraschi, R. Lencioni, D. Caramella, and C. Bartolozzi Colorectal Cancer: Role of CT Colonography in Preoperative Evaluation after Incomplete Colonoscopy Radiology, June 1, 2002; 223(3): 615 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sonnenberg and F. Delco Cost-effectiveness of a Single Colonoscopy in Screening for Colorectal Cancer Arch Intern Med, January 28, 2002; 162(2): 163 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. La Vecchia Fecal occult blood screening for colorectal cancer: open issues Ann. Onc., January 19, 2002; 13(1): 31 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Barry Fecal occult blood testing for colorectal cancer: a perspective Ann. Onc., January 19, 2002; 13(1): 61 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Lewis, A. Brown, A. R. Localio, and J. S. Schwartz Initial Evaluation of Rectal Bleeding in Young Persons: A Cost-Effectiveness Analysis Ann Intern Med, January 15, 2002; 136(2): 99 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Ransohoff and R. S. Sandler Screening for Colorectal Cancer N. Engl. J. Med., January 3, 2002; 346(1): 40 - 44. [Full Text] [PDF]
|
|
|
|
|
|
U. Ladabaum, C. L. Chopra, G. Huang, J. M. Scheiman, M. E. Chernew, and A. M. Fendrick Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis Ann Intern Med, November 6, 2001; 135(9): 769 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Ferrucci Colon Cancer Screening with Virtual Colonoscopy: Promise, Polyps, Politics Am. J. Roentgenol., November 1, 2001; 177(5): 975 - 988. [Full Text] [PDF]
|
|
|
|
|
|
M. K. Chelmowski Cost-Effectiveness of Screening for Colorectal Cancer Ann Intern Med, August 7, 2001; 135(3): 218 - 218. [Full Text] [PDF]
|
|
|
|
|
|
B. Budenholzer and H. G. Welch Cost-Effectiveness of Screening for Colorectal Cancer Ann Intern Med, August 7, 2001; 135(3): 219 - 219. [Full Text] [PDF]
|
|
|
|
|
|
A. Das Cost-Effectiveness of Screening for Colorectal Cancer Ann Intern Med, August 7, 2001; 135(3): 218 - 218. [Full Text] [PDF]
|
|
|
|
|
|
B. Budenholzer, H. G. Welch, M. Donohoe, S. N. Glick, A. L. Frazier, and K. M. Kuntz Cost-effectiveness of Colorectal Cancer Screening JAMA, January 24, 2001; 285(4): 407 - 408. [Full Text] [PDF]
|
|
|
|
 |
|
 Colorectal Cancer Screening: Any Is Better than None Journal Watch Dermatology, December 22, 2000; 2000(1222): 9 - 9. [Full Text]
|
|
|
|
|
|
S. H. Woolf The Best Screening Test for Colorectal Cancer -- A Personal Choice N. Engl. J. Med., November 30, 2000; 343(22): 1641 - 1643. [Full Text]
|
|
|
|
 |
|
 Colonoscopy for Colorectal Cancer Screening Journal Watch Women's Health, November 13, 2000; 2000(1113): 4 - 4. [Full Text]
|
|
|
|
 |
|
 Colorectal Cancer Screening: Any Is Better than None Journal Watch (General), November 3, 2000; 2000(1103): 3 - 3. [Full Text]
|
|
|
|
|
|
J. D. Lewis Prevention and Treatment of Colorectal Cancer: Pay Now or Pay Later Ann Intern Med, October 17, 2000; 133(8): 647 - 649. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
